Presentation ACC 2017 Everolimus-eluting Bioresorbable Vascular Scaffolds in Patients with Coronary Artery Disease: ABSORB III Trial 2-Year Results Presenter: Stephen G. Ellis March 19, 2017
Presentation ACC 2016 Outcomes of the ABSORB Bioresorbable Vascular Scaffold in Very Small and Not Very Small Coronary Arteries: The ABSORB III randomized trial Presenter: Gregg W. Stone April 03, 2016